Skip to contentP
Petmed Express Inc
P
PETSPetmed Express Inc Q4 2021 · 10-K
Revenue$71.68M$71.68M−3.5% vs Q4 2020 Net Income$6.81M$6.81M−2.7% vs Q4 2020 EPS Diluted$0.34$0.34−2.9% vs Q4 2020 Gross Profit$20,522,000−5.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
Operating Cash Flowderived$18,449,000+6.9% Free Cash Flowderived$17,865,000+6.5% Margins · derivedGross margin28.6%−0.6 pt vs Q4 2020
Operating margin11.7%+0.2 pt vs Q4 2020
Net margin9.5%+0.1 pt vs Q4 2020
ended Mar 31, 2021 · filed May 25, 2021 · 55 d after period end